Xtant Story

XTNT -- USA Stock

USD 1.91 0.01 0.52%

Macroaxis Story

The stock is currently undergoing an active upward rally. While some private investors are becoming indifferent towards healthcare space, we are going to review the feasibility of acquiring Xtant as a potential hedging instrument for your current portfolios. We will evaluate why recent Xtant Medical price moves suggest a bounce in March.

Published over a month ago

View all stories for Xtant Medical | View All Stories

Do analysts believe Xtant Medical (AMEX:XTNT) will continue to gain?

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xtant Medical has an asset utilization ratio of 39.91 percent. This implies that the company is making $0.4 for each dollar of assets. An increasing asset utilization means that Xtant Medical Holdings is more efficient with each dollar of assets it utilizes for everyday operations.

What is the right price you would pay to acquire a share of Xtant Medical? For most investors, it would be the price that gives them a wide margin of safety to have minimal downside risk. In other words, most investors are always looking for undervalued stocks. Even if the future performance is not entirely as expected, the loss of holding it is minimized, and the downside risk is negated.

Please read more on our stock advisor page.

How important is Xtant Medical's Liquidity

Xtant Medical financial leverage refers to using borrowed capital as a funding source to finance Xtant Medical Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Xtant Medical financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Xtant Medical's total debt and its cash.

How Xtant utilizes its cash?

To perform a cash flow analysis of Xtant Medical, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Xtant Medical is receiving and how much cash it distributes out in a given period. The Xtant Medical cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.

Xtant Medical Net Cash Flow from Operations is comparatively stable at the moment as compared to the past year. Xtant Medical reported Net Cash Flow from Operations of (16.57 Million) in 2020

Is Xtant a risky opportunity?

Let's check the volatility. Xtant is looking slightly risky at this time. Whether you invest your money or manage your clients' funds, remember that it is easy to forget that behind Xtant (AMEX:XTNT) stock is an actual business venture. So, do not let stock picking become an abstract concept by ignoring the elementary risk calculations. acquiring a share of a Xtant Medical stock makes you a part-owner of that company.

Will Xtant Medical newest gain continue?

Xtant Medical newest total risk alpha boosts over 0.13. Xtant Medical Holdings exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Xtant Medical Holdings individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Xtant Medical future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Xtant Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Xtant Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Our Final Take On Xtant Medical

Whereas some firms within the medical devices industry are still a little expensive, even after the recent corrections, Xtant Medical may offer a potential longer-term growth to private investors. To conclude, as of the 27th of February 2021, our current 30 days buy-hold-sell advice on the firm is Strong Sell. We believe Xtant Medical is overvalued with below average probability of distress for the next two years.

About Contributor

Ellen Johnson is a Member of Macroaxs Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Xtant Medical Holdings. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC